Clinical Edge Journal Scan

Moisturizer containing urea and glycerol shows skin barrier-strengthening effects in atopic dermatitis


 

Key clinical point: A 4-week treatment with a test cream (TC) containing only 2% urea and 20% glycerol significantly reduced sodium lauryl sulphate-induced skin irritation in patients with atopic dermatitis (AD) compared with a no treatment control (NTC) and two reference creams.

Major finding: After 28 days, there was a significant reduction in transepidermal water loss with TC vs. NTC ( P < .001), paraffin cream ( P < .001), and glycerol cream ( P = .021); objective redness was lower with TC vs. NTC ( P = .002) and paraffin cream ( P < .001). The TC was well tolerated with no evidence of stinging or redness.

Study details: Findings are from a phase 2 trial including 49 adults with AD who were randomly assigned to receive either a TC containing urea and glycerol, a glycerol-containing moisturizer, a simple paraffin cream containing no humectant, or NTC.

Disclosures: This study was funded by Perrigo Nordic. The authors declared serving as consultants, investigators, or advisory board members for and receiving research grants from several sources. Three authors declared being employees of Perrigo Nordic.

Source: Danby SG et al. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis. Clin Exp Dermatol. 2022 (Feb 15). Doi: 10.1111/ced.15141

Recommended Reading

Risk for infection in children and adolescents with atopic dermatitis treated with dupilumab
MDedge Dermatology
Atopic dermatitis: Dupilumab effective and safe in real world
MDedge Dermatology
Reduced hospitalization risk with dupilumab in moderate-to-severe atopic dermatitis
MDedge Dermatology
Clinical Edge Journal Scan Commentary: Atopic Dermatitis March 2022
MDedge Dermatology
An Update on JAK Inhibitors in Skin Disease
MDedge Dermatology
Wet Your Whistles: Alcohol-Induced Flushing With Use of Topical Calcineurin Inhibitors
MDedge Dermatology
Patch Testing on Dupilumab: Reliable or Not?
MDedge Dermatology
Managing overuse of food IgE panels: Multiple approaches needed
MDedge Dermatology
The Impact of Prenatal Nutrition on the Development of Atopic Dermatitis in Infancy and Childhood
MDedge Dermatology
Upadacitinib shows favorable long-term benefit-risk profile in moderate-to-severe atopic dermatitis
MDedge Dermatology